Where does BVXV stock trade?

BiondVax Pharmaceuticals Ltd. (BVXV) is listed on NASDAQ.

What sector and industry is BVXV in?

BiondVax Pharmaceuticals Ltd. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.

When did BiondVax Pharmaceuticals Ltd. go public?

BiondVax Pharmaceuticals Ltd. (BVXV) completed its IPO in 2015.

What are analysts saying about BVXV?

BiondVax Pharmaceuticals Ltd. has had 1 recent analyst action on file. The most recent action was from Aegis Capital: Buy with a $700.00 price target on 2022-01-26. Recent price targets cluster around $700.00.

What companies are similar to BVXV?

Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare BVXV side-by-side with any of them on Quantisnow.

How can I track BVXV on Quantisnow?

Quantisnow aggregates BiondVax Pharmaceuticals Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BVXV to receive live email and push alerts on every new disclosure.

BVXV

NASDAQ

BiondVax Pharmaceuticals Ltd.

SectorHealth CareIndustryBiotechnology: Biological Products (No Diagnostic Substances)IPO2015

$1.32-0.03 (-2.22%)

Follow Website

News25/Ratings1

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and related illnesses in Israel. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Latest news

25 items

BVXV FAQ

7 questions

What does BiondVax Pharmaceuticals Ltd. do?
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and related illnesses in Israel. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.
Where does BVXV stock trade?
BiondVax Pharmaceuticals Ltd. (BVXV) is listed on NASDAQ.
What sector and industry is BVXV in?
BiondVax Pharmaceuticals Ltd. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.
When did BiondVax Pharmaceuticals Ltd. go public?
BiondVax Pharmaceuticals Ltd. (BVXV) completed its IPO in 2015.
What are analysts saying about BVXV?
BiondVax Pharmaceuticals Ltd. has had 1 recent analyst action on file. The most recent action was from Aegis Capital: Buy with a $700.00 price target on 2022-01-26. Recent price targets cluster around $700.00.
What companies are similar to BVXV?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare BVXV side-by-side with any of them on Quantisnow.
How can I track BVXV on Quantisnow?
Quantisnow aggregates BiondVax Pharmaceuticals Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BVXV to receive live email and push alerts on every new disclosure.